Modulation of a competitive N-methyl-D-aspartate receptor antagonist binding by zinc oxide

Brain Research

Volumn 744, Issue 2, 1997, Pages 347-350

  Terse, Pramod S ^a   Komiskey, Harold L ^a  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

CGP 39653; glutamate; glycine; N methyl D aspartate; receptor; zinc oxide

Indexed keywords

2 AMINO 4 PHOSPHONOMETHYL 3 HEPTENOIC ACID; GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RADIOLIGAND; ZINC OXIDE;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; BINDING SITES; EXCITATORY AMINO ACID ANTAGONISTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; ZINC OXIDE;

EID: 0031023620     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01204-8     Document Type: Article

References (34)

1. 2+ from brain tissue during activity, Nature, 308 (1984) 734-736.
2. Boast, C.A., Gerhardt, S.C., Pastor, G., Lehmann, J., Etienne, P.E. and Liebman, J.M., The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils, Brain Res., 442 (1988) 345-348.
3. Bullock, R., McCulloch, J., Graham, D.L., Lowe, D., Chen, M.H. and Teasdale, G.M., Focal ischemic damage is reduced by CPP-ene studies in two animal models, Stroke, 21, Suppl. (1990) 32-36.
4. Choi, D.W., Glutamate neurotoxicity and disease of the nervous system, Trends Neurosci., 1 (1988) 628-634.
5. Fagg, G.E., Olpe, H.R., Pozza, M.F., Baud, J., Steinmann, M., Schmutz, M., Portet, C., Baumann, P., Thedinga, K., Bittiger, H., Allgeier, H., Heckendorn, R., Angst, C., Brundish, D. and Dingwall, J.G., CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity, Br. J. Pharmacol., 99 (1990) 791-197.
6. Forsythe, I.D., Westbrook, G.L. and Mayer, M.L., Modulation of excitatory synaptic transmission by glycine and zinc in cultures of mouse hippocampal neurons, J. Neurosci., 8 (1988) 3733-3741.
7. Frederickson, C.J., Klitenick, M.A., Manton, W.I. and Kirkpatrick, J.B., Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat, Brain Res., 273 (1983) 335-339.
8. Goldberg, M.P., Veseskul, V. and Choi, D.W., Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia, J. Pharmacol. Exp. Ther., 45 (1988) 1081-1087.
9. Gill, R., Foster, A. and Woodruff, G.N., Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil, J. Neurosci., 7 (1987) 3345-3349.
10. Howell, G.H., Welch, M.G. and Frederickson, C.J., Stimulation-induced uptake and release of zinc in hippocampal slices, Nature, 308 (1984) 736-738.
11. Hu, K.H. and Friede, R.L., Topographic determination of zinc in human brain by atomic absorption spectrophotometer, J. Neural., 15 (1986) 677-685.
12. Koh, J.Y. and Choi, D.W., Zinc toxicity on cultured cortical neurons: involvement of N-methyl-D-aspartate receptors, Neuroscience, 60 (1994) 1049-1057.
13. Komiskey, H.L., Onomo, J.P., Terse, P.S., Smith, D.E., Gonzales, C.R., Mielke, H.W. and Harper, J., Metal concentrations and histopathology of brain after subchronic zinc oxide, Toxicologist, 30 (1996) 262.
14. Lodge, D. and Collingridge, G., The pharmacology of excitatory amino acids: a TiPS special report, Trends Pharmacol. Sci., special issue (1991) 1-89.
15. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
16. Mayer, M.L. and Vyklicky Jr., L., The action of zinc on synaptic transmission and neuronal excitability in cultures of mouse hippocampus, J. Physiol., 415 (1989) 351-365.
17. Mayer, M.L., Westbrook, G.L. and Vyklicky, L., Sites of antagonist action on N-methyl-D-aspartic acid receptors studied using fluctuation analysis and rapid perfusion technique, J. Neurophysiol., 60 (1988) 645-663.
18. McCulloch, J., Ischemic brain damage - prevention with competitive and non-competitive antagonists of N-methyl-D-aspartate receptors, Arzneimittelforschung, 41 (1991) 319-324.
19. McCulloch, J., Excitatory amino acid antagonists and their potential for the treatment of ischemic brain damage in man, Br. J. Clin. Pharmacol., 34 (1992) 106-114.
20. Meldrum, B., Pharmacology of excitatory amino acid antagonists and their possible therapeutic use in neurological disease. In J.A. Ferrendelli. R.C. Collins and E.M. Johnson (Eds.), Neurobiology of Amino Acids, Peptides and Trophic Factors, 1988, pp. 63-77.
21. Olney, J., Price, M., Salles, K.S., Labruyère, J. and Friedrich. G., MK-801 powerfully protects against N-methyl-D-aspartate neurotoxicity, Eur. J. Pharmacol., 141 (1987) 357-361.
22. Olney, J.W., Labruyère, J., Wang, G., Wozniak, D.F., Price, M.T. and Sesma, M.A., NMDA antagonist neurotoxicity: mechanism and prevention, Science, 254 (1991) 1515-1518.
23. Perez-Clausell, J. and Danscher, G., Intravesicular localization of zinc in rat telencephalic boutons. A histochemical study, Brain Res., 337 (1985) 91-98.
24. Peters, S., Koh, J. and Choi, D.W., Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons. Science, 236 (1987) 589-593.
25. Reynolds, I.J., Modulation of NMDA receptor responsiveness by neurotransmitters, drugs and chemical modification. Life Sci., 47 (1990) 1785-1792.
26. 2+ and polyamines independently of the arcaine-sensitive polyamine site, J. Neurochem., 62 (1994) 54-62.
27. SAS Institute Inc., SAS / STAT Guide for Personal Computers, SAS Institute, Carry, NC, 1994.
28. Serra, M., Ghiani, C.A., Foddi, M.C., Motzo, C. and Biggio, G., NMDA receptor function is enhanced in the hippocampus of aged rats, Neurochem. Res., 19 (1994) 483-487.
29. 3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain. Eur. J. Pharmacol., 192 (1991) 19-24.
30. Simon, R.P., Swan, J.H., Griffiths, T. and Meldrum, B.S., Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain, Science, 226 (1984) 850-852.
31. Yeh, G., Bonhaus, D.W. and McNamara, J.O., Evidence that zinc inhibits N-methyl-D-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding, Mol. Pharmacol., 38 (1990) 14-19.
32. 2+ antagonize NMDA and GABA responses of hippocampal neurons, Nature, 328 (1987) 640-643.
33. Woodburn, V.L. and Woodruff, G.N., Neuroprotective actions of excitatory amino acid receptor antagonists, Adv. Pharmacol., 30 (1994) 1-33.
34. Woodruff, G.N., Foster, A.C., Gill, R., Kemp, J.A., Wong, E.H.F. and Iversen, L.L., The interactions between MK-801 and receptors for N-methyl-D-aspartate: functional consequences, Neuropharmacology. 26 (1987) 903-909.